Bristol Myers Squibb BMY
NYSE BMY
$63.88 +1.02 (+1.62%)
As of: Sep 28, 2026 · 3:59 PM EDT

Bristol Myers Squibb (BMY) Long-Term Debt Repayments (2009 - 2026)

Updated

Bristol Myers Squibb's Long-Term Debt Repayments came in at $1.22 billion for Q2 2026, up 89.7% from $643 million a year earlier and up 144.0% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Long-Term Debt Repayments (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bristol Myers Squibb reported Long-Term Debt Repayments of $12.02 billion, up 285.0% year-over-year; for FY2025, it was $10.94 billion, up 280.8% from FY2024.

  • Long-Term Debt Repayments carries a five-year compound annual growth rate of 31.8% (FY2020 to FY2025).
  • Going back by year, Long-Term Debt Repayments was $2.87 billion in FY2024 (-25.9%), $3.88 billion in FY2023 (-66.1%), $11.43 billion in FY2022 (+89.8%) and $6.02 billion in FY2021 (+119.0%).
  • The five-year range for quarterly Long-Term Debt Repayments is $229 million (Q3 2025) to $10.07 billion (Q4 2025).
  • The fastest year-over-year change in Long-Term Debt Repayments over five years came in Q3 2022 (growth of 457.0%), and the weakest in Q2 2023 (a decline of 91.7%).
  • Business Quant data shows BMY's Long-Term Debt Repayments at $500 million (Q1 2026), $10.07 billion (Q4 2025) and $229 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 1.00 Mn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 2.00 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -2.45 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 17.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 1.22 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Bn
Mar 31, 2026 500.00 Mn
Dec 31, 2025 10.07 Bn
Sep 30, 2025 229.00 Mn
Jun 30, 2025 643.00 Mn
Sep 30, 2024 2.48 Bn
Jun 30, 2024 395.00 Mn
Dec 31, 2023 2.00 Bn
Jun 30, 2023 239.00 Mn
Mar 31, 2023 1.64 Bn
Sep 30, 2022 2.79 Bn
Jun 30, 2022 2.88 Bn
Mar 31, 2022 5.77 Bn
Sep 30, 2021 500.00 Mn
Jun 30, 2021 1.00 Bn
Mar 31, 2021 4.52 Bn
Dec 31, 2020 1.25 Bn
Sep 30, 2020 1.50 Bn
Dec 31, 2019 8.00 Bn
Jun 30, 2019 6.00 Mn
API Access

Bristol Myers Squibb Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=BMY&period=max&api_key=YOUR_API_KEY